Code of Federal Regulations, Title 21, § 201.57¶
U.S. Food and Drug Administration. Code of Federal Regulations, Title 21, § 201.57: Specific Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products Described in § 201.56(b)(1). Electronic Code of Federal Regulations.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Mechanisms¶
- Clinical Protocol Definition
- A contraindication is exactly the boundary
This sourceDefines contraindications as situations in which a drug should not be used because the risk clearly outweighs any possible benefit.
- A contraindication is exactly the boundary
Verification¶
Does it exist? Not checked yet. This entry carries no identifier to resolve. It was extracted from the citation as written in the article, normalized, and deduplicated against the rest of the registry.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:f0dbabcd64eb · see in the full table